Barclays PLC Sells 188,297 Shares of The Cooper Companies, Inc.

Barclays decreases stake in medical device company

Mar. 11, 2026 at 7:33am

Got story updates? Submit your updates here. ›

Barclays PLC decreased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 28.5% in the third quarter, according to the company's recent 13F filing with the Securities and Exchange Commission (SEC). Barclays now owns 471,430 shares of the medical device company's stock, down from 659,727 shares previously.

Why it matters

The Cooper Companies is a major player in the vision care and women's health products markets, and changes in ownership by large institutional investors like Barclays can signal shifts in market sentiment or strategic direction for the company.

The details

In its 13F filing, Barclays reported selling 188,297 shares of The Cooper Companies during the third quarter. The firm now owns approximately 0.24% of the company's outstanding shares, down from 0.34% previously. The sale comes as Cooper Companies has seen its stock price fluctuate in recent months, with shares trading between $61.78 and $89.83 over the past 52 weeks.

  • Barclays decreased its holdings in The Cooper Companies during the third quarter of 2026.

The players

Barclays PLC

A multinational investment bank and financial services company headquartered in London, England.

The Cooper Companies, Inc.

A global medical device company headquartered in San Ramon, California that develops, manufactures and markets a broad range of soft contact lenses and women's health products.

Got photos? Submit your photos here. ›

The takeaway

The decrease in Barclays' stake in The Cooper Companies reflects broader market volatility and uncertainty around the medical device sector, but the company remains a major player in its key product categories.